Centaurus Biopharma Co., Ltd.
2 clinical trials · Sponsor
◉ Watch Centaurus Biopharma Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Study of Safety,Efficacy and Pharmacokinetics of CT-1530 in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia (NCT02981745) | Centaurus Biopharma Co., Ltd. | 2017-04-01 |
| Study of Safety, Efficacy and Pharmacokinetics of CT-707 in Patients With ALK-positive Non-small Cell Lung Cancer (NCT02695550) | Centaurus Biopharma Co., Ltd. | 2016-03-01 |
Track Centaurus Biopharma Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.